Suppr超能文献

用 8 色流式细胞术检测骨髓和外周血干细胞采集物中的 CD34+ 细胞亚群:白血病患者微小残留病检测的应用。

CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.

机构信息

Department of Pathology, Karolinska University Hospital, Solna and Karolinska Institute, 171 76, Stockholm, Sweden.

Department of Medicine, Division of Hematology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Int J Hematol. 2009 Oct;90(3):292-302. doi: 10.1007/s12185-009-0389-z. Epub 2009 Aug 29.

Abstract

Fast development in polychromatic flow cytometry (PFC) makes it possible to study CD34+ cells with two scatter and eight fluorescence parameters. Minimal residual disease (MRD) is determined as persistence of leukemic cells at submicroscopic levels in bone marrow (BM) of patients in complete remission. MRD can be present in collections of hematopoietic stem cell from blood (HSC-B). Using PFC, we have defined patterns of antigen expression in CD34+ cell subpopulations in BM and applied them as templates in MRD analysis. Twelve BM samples from hospital control (HC) patients with no signs of hematological malignancy were studied using five 8-color monoclonal antibody combinations detecting subsets of CD34+ cells. These patterns have been used as templates to determine levels of MRD in HSC-B collections from six AML patients. Several subsets of CD34+ precursor cells were found to be present at very low frequencies (<10(-4)) in BM and/or HSC-B collections. All six HSC-B collections from AML patients showed MRD by 8-color technique and only three by previously applied 3-color method. The 8-color technique showed promising results in efficient detection of different CD34+ subpopulations of HSC-B and in MRD quantification. Monitoring of MRD should become a part of quality control of HSC-B collections.

摘要

多色流式细胞术(PFC)的快速发展使得研究 CD34+细胞的两个散射和八个荧光参数成为可能。微小残留病(MRD)是指在完全缓解的患者骨髓(BM)中以亚微观水平存在白血病细胞。MRD 可存在于血液中的造血干细胞(HSC-B)采集物中。我们使用 PFC 定义了 BM 中 CD34+细胞亚群的抗原表达模式,并将其应用于 MRD 分析的模板。使用五种 8 色单克隆抗体组合检测 CD34+细胞亚群,研究了 12 名来自医院对照(HC)患者的 BM 样本,这些患者没有血液恶性肿瘤的迹象。这些模式已被用作模板,以确定来自 6 名 AML 患者的 HSC-B 采集物中的 MRD 水平。在 BM 和/或 HSC-B 采集物中发现了几个 CD34+前体细胞亚群的存在频率非常低(<10(-4))。通过 8 色技术,所有 6 名 AML 患者的 HSC-B 采集物均显示 MRD,而通过先前应用的 3 色方法仅显示 3 名。8 色技术在有效检测 HSC-B 中不同 CD34+亚群和 MRD 定量方面显示出良好的效果。MRD 的监测应成为 HSC-B 采集物质量控制的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验